ArticleFrontiers in medicine2026

Quantitative HBsAg as a biomarker for disease staging in untreated chronic hepatitis B patients: a cross-sectional study.

Soumaya Mrabet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.